US Therapeutic Plasma Exchange Market worth $260 million by 2021 | Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Baxter International Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan)

The report "US Therapeutic Plasma Exchange Market Size & Share by Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis), Indication (Neurological & Autoimmune Disorders) - Forecasts to 2021", The overall market of US therapeutic plasma exchange is estimated to reach $260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period.

Browse 55 market data Tables and 10 Figures spread through 91 Pages and in-depth TOC on "US Therapeutic Plasma Exchange Market"
https://www.marketsandmarkets.com/Market-Reports/us-therapeutic-plasma-exchange-market-87153046.html

The growing prevalence of neurological diseases; increasing adoption of TPE procedures in rare disorders such as Guillain-Barré syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Neuromylitis Optica, Thrombotic Thrombocytopenic Purpura (TTP), and Cryoglobulinaemia; and growing awareness about the increasing clinical response rate of TPE procedures in various diseases in the US are driving the growth in US Therapeutic Plasma Exchange Market segment. However, factors such as high cost of therapeutic plasma exchange procedures, lack of awareness about the TPE process, lack of skilled professionals, and risks associated with therapeutic plasma exchange procedure are restraining the growth of the US therapeutic plasma exchange market to a certain extent.

Early buyers will receive 10% customization on reports.
Get 10% FREE Customization on this report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=87153046&utm_source=OpenPR_23_Jan_2019&utm_medium=Paid-PR

The overall market of US therapeutic plasma exchange is broadly segmented into neurological disorders, hematology disorders, renal disorders, autoimmune disorders, and metabolic disorders. In 2015, the neurological disorders segment accounted for the largest share of the US therapeutic plasma exchange market; this segment is also projected to grow at the highest CAGR during the forecast period. The growing prevalence of neurological diseases; increasing clinical response rate for therapeutic plasma exchange in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis; and growing prevalence of multiple sclerosis in the U.S. are driving the growth in this market segment.

This study also provides information on the number of patients treated and the total number of TPE procedures performed for various diseases. Some of the major players in the US therapeutic plasma exchange market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Baxter International Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), B. Braun Melsungen AG (Germany), and HemaCare Corporation (U.S.).

Read More: https://www.marketsandmarkets.com/PressReleases/us-therapeutic-plasma-exchange.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/us-therapeutic-plasma-exchange-market.asp

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441

UK : +44-800-368-9399
sales@marketsandmarkets.com

This release was published on openPR.